Jenscare Scientific Co., Ltd. (HKG:9877)
Hong Kong · Delayed Price · Currency is HKD 7.20
+0.02 (0.28%)
Sep 11, 2026, 4:08 PM HKT
Jenscare Scientific Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 141.29 | 90.59 | - | - | - | - | |
Revenue Growth | 952.38% | - | - | - | - | - |
Cost of Revenue | 15.12 | 8.07 | - | - | - | - |
Gross Profit | 126.17 | 82.52 | - | - | - | - |
Selling, General & Admin | 123.26 | 128.44 | 68.18 | 150.31 | 219.7 | 238.51 |
Research & Development | 147.3 | 183.61 | 142.64 | 288.15 | 291.58 | 265.34 |
Operating Expenses | 272.53 | 314.02 | 210.82 | 438.46 | 511.28 | 503.84 |
Operating Income | -146.36 | -231.5 | -210.82 | -438.46 | -511.28 | -503.84 |
Interest Expense | -1.4 | -0.87 | -0.29 | -0.14 | -0.11 | -0.13 |
Interest & Investment Income | 12.26 | 13.82 | 11.25 | 19.33 | 8.36 | 1.77 |
Earnings From Equity Investments | - | - | - | 18.95 | 16.17 | 1.34 |
Currency Exchange Gain (Loss) | -11.84 | -13.47 | 2.91 | 3.17 | 34.62 | -6.84 |
Other Non Operating Income (Expenses) | -4.83 | -42.11 | 7.06 | 18.24 | 10.62 | 0.54 |
EBT Excluding Unusual Items | -152.16 | -274.12 | -189.89 | -378.92 | -441.62 | -507.16 |
Gain (Loss) on Sale of Investments | 1.01 | 1.75 | 10.84 | -0.17 | 0.72 | 6.49 |
Gain (Loss) on Sale of Assets | -0.03 | -0.04 | -0.09 | -0.01 | -0.01 | - |
Asset Writedown | - | -0.29 | -6.69 | - | - | - |
Pretax Income | -151.18 | -272.7 | -185.83 | -379.1 | -440.91 | -500.67 |
Earnings From Continuing Operations | -151.18 | -272.7 | -185.83 | -379.1 | -440.91 | -500.67 |
Minority Interest in Earnings | 0.82 | 1.48 | 8.32 | 7.36 | 1.6 | 0.16 |
Net Income | -150.35 | -271.23 | -177.51 | -371.74 | -439.31 | -500.52 |
Net Income to Common | -150.35 | -271.23 | -177.51 | -371.74 | -439.31 | -500.52 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 434 | 425 | 409 | 417 | 365 | 338 |
Shares Outstanding (Diluted) | 434 | 425 | 409 | 417 | 365 | 338 |
Shares Change | 6.54% | 4.02% | -1.97% | 14.17% | 7.96% | 21.43% |
EPS (Basic) | -0.35 | -0.64 | -0.43 | -0.89 | -1.20 | -1.48 |
EPS (Diluted) | -0.35 | -0.64 | -0.43 | -0.89 | -1.20 | -1.48 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -78.24 | -288.81 | -300.64 | -180.14 | -155.17 |
Free Cash Flow Per Share | - | -0.18 | -0.71 | -0.72 | -0.49 | -0.46 |
Gross Margin | 89.30% | 91.09% | - | - | - | - |
Operating Margin | -103.58% | -255.55% | - | - | - | - |
Profit Margin | -106.41% | -299.41% | - | - | - | - |
Free Cash Flow Margin | - | -86.37% | - | - | - | - |
EBITDA | -133.72 | -220.42 | -201.62 | -429.68 | -504.82 | -500.44 |
EBITDA Margin | -94.64% | -243.32% | - | - | - | - |
D&A For EBITDA | 12.64 | 11.08 | 9.2 | 8.78 | 6.46 | 3.41 |
EBIT | -146.36 | -231.5 | -210.82 | -438.46 | -511.28 | -503.84 |
EBIT Margin | -103.58% | -255.55% | - | - | - | - |